Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
500.00    0.00 (0.00%)
Bid:
499.80
Ask:
500.50
Spread: 0.70 (0.14%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARDS

20 Dec 2012 07:00

RNS Number : 9754T
Chemring Group PLC
20 December 2012
 



FOR IMMEDIATE RELEASE 20 December 2012

 

 

CHEMRING GROUP PLC

 NIITEK AWARDED $32 MILLION ADDITIONAL HMDS IDIQ DELIVERY ORDERS

 

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiary, Non-Intrusive Inspection Technology, Inc. ("NIITEK"), has been awarded two additional delivery orders totaling $32 million to provide spares for both the US Army and US Marine Corps. These delivery orders are issued as part of the multi-year Husky Mounted Detection System ("HMDS") Ground Penetrating Radar ("GPR") Indefinite-Delivery/Indefinite-Quantity ("IDIQ") contract that was awarded on 30 April 2012. This contract not only provides the US Army with the ability to procure spares and replacement systems to replenish theatre sustainment stock, but also provides the ability to serve future system requirements for the US Marine Corps and potential Foreign Military Sales. The potential value of the IDIQ contract is $579 million, with performance into 2013.

Mark Papworth, Chief Executive of Chemring, commented:

"We are delighted that these additional delivery orders enable us to continue our vital support to the US Army and US Marine Corps with NIITEK's HMDS products. Since the inception of the HMDS over four years ago, our commitment remains to provide the best explosives and mine detection capability to US and coalition forces currently in combat, as well as looking ahead to support them as they stand ready to conduct operations around the world."

-ENDS-

 

Chemring Group PLC

Rupert Pittman Director of Communications and Investor Relations

01489 881 880 / rupertp@chemring.co.uk

 

MHP Communications

Andrew Jaques / James White

0203 128 8100

 

Notes to Editors:

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over eighty countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. NIITEK, a Chemring company since 2008, is the world leader in the design, development and production of Advanced Ground Penetrating Radar ("GPR") systems. NIITEK's Advanced GPR systems are at the leading edge of mine detection technology with over two hundred systems successfully being used by US and Coalition forces in Afghanistan.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFFLEFUFESEIE
Date   Source Headline
30th Aug 20224:13 pmRNSHolding(s) in Company
25th Aug 20222:42 pmRNSHolding(s) in Company
1st Aug 20224:23 pmRNSTotal Voting Rights
11th Jul 202210:54 amRNSDirector/PDMR Shareholding
8th Jul 20221:09 pmRNSHolding(s) in Company
5th Jul 20229:22 amRNSHolding(s) in Company
1st Jul 20229:35 amRNSTotal Voting Rights
1st Jul 20227:00 amRNSClosure of SFO investigation
28th Jun 20225:22 pmRNSDirector/PDMR Shareholding
20th Jun 20224:54 pmRNSBlock listing Interim Review
20th Jun 20224:46 pmRNSBlock listing update
8th Jun 20227:00 amRNSINTERIM RESULTS
1st Jun 202210:07 amRNSTotal Voting Rights
9th May 202211:55 amRNSTotal Voting Rights
19th Apr 20222:00 pmRNSHolding(s) in Company
6th Apr 20227:19 amRNSDirector Declaration
1st Apr 202210:00 amRNSTotal Voting Rights
28th Mar 20228:12 amRNSDirector Declaration
23rd Mar 20222:31 pmRNSDirector/PDMR Shareholding
23rd Mar 202210:50 amRNSDirector/PDMR Shareholding
23rd Mar 202210:47 amRNSDirector/PDMR Shareholding
23rd Mar 202210:46 amRNSDirector/PDMR Shareholding
15th Mar 202210:33 amRNSDirector/PDMR Shareholding
4th Mar 202211:32 amRNSDoc re. Ordinary & Special Resolutions
3rd Mar 20222:53 pmRNSResult of AGM
3rd Mar 20227:00 amRNSAGM Update
1st Mar 20222:57 pmRNSTotal Voting Rights
1st Feb 202211:40 amRNSTotal Voting Rights
17th Jan 202211:06 amRNSNotice of AGM
14th Jan 20222:15 pmRNSAdditional Listing
6th Jan 20224:56 pmRNSHolding(s) in Company
4th Jan 202210:22 amRNSTotal Voting Rights
21st Dec 202111:00 amRNSBlock listing Interim Review
21st Dec 202110:56 amRNSBlock listing Update
15th Dec 20212:00 pmRNSDirector/PDMR Shareholding
15th Dec 20212:00 pmRNSDirector/PDMR Shareholding
15th Dec 20212:00 pmRNSDirector/PDMR Shareholding
15th Dec 20212:00 pmRNSDirector/PDMR Shareholding
15th Dec 20212:00 pmRNSDirector/PDMR Shareholding
15th Dec 20212:00 pmRNSDirector/PDMR Shareholding
14th Dec 20214:36 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSResults for the year ended 31 October 2021
1st Dec 202110:04 amRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading Update and Contract Awards
1st Nov 20213:37 pmRNSTotal Voting Rights
8th Oct 20217:00 amRNSStatement re CFC Finance Company Exemption
1st Oct 20219:34 amRNSTotal Voting Rights
28th Sep 20217:00 amRNSContract Awards
14th Sep 20217:00 amRNSScheduled Trading Update
1st Sep 202110:11 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.